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1682-606X/Copyright ª 2015, TaiwanAbstract Esthesioneuroblastoma, also knownas olfactory neuroblastoma, is a rare typeof neu-
roectodermal tumor arising from the superior portion of the nasal cavity, sometimes locally
invading the anterior skull base. We report the case of a 44-year-old man having a 3-year history
of nasal obstruction and anosmia, acute worsening of vision in his right eye, and facial numbness
on the right side. Brain computed tomography and magnetic resonance imaging revealed an
extensively enhanced soft tissue tumor involving bilateral nasal and orbital cavities, ethmoid si-
nuses, the floor of the anterior cranial fossa, and intradural invasion. In particular, prominent hy-
perostosis, a rare associated radiological finding, was observed on both sides of the orbital roofs.
Bifrontobasal craniotomy involving a radical removal of the soft tissue mass, including the intra-
dural extension, was performed; the bilateral hyperostosis of the orbital roofs was drilled off for
decompression of the narrowed orbital cavities. Pathological reports confirmed esthesioneuro-
blastoma. The postoperative course was smooth, and the vision improved. The tumor did not
recur for 1 year after postoperative radiotherapy and adjuvant chemotherapy.
Copyright ª 2015, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
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Figure 1 Preoperative coronal images of (A) the contrast
brain computed tomography and (B) contrast-enhanced T1-
weighted magnetic resonance imaging reveals an extensively
enhanced soft tissue tumor involving the bilateral nasal and
orbital cavities, ethmoid sinuses, the floor of the anterior
cranial fossa, and the posterior part of the cribriform plate,
with hyperostotic bones (arrows) at the anterior cranial fossa
base.
182 K.-F. Huang et al.postoperative radiotherapy and chemotherapy. The overall
prognosis mainly depends on the histological grade and
severity of the tumor invasion.2
Associated hyperostosis of the anterior skull base is
extremely rare for patients with ENBs. Meningioma-
associated hyperostosis is relatively common, generally
localized, and proportional to the tumor size; the potential
pathogenesis of tumor-associated hyperostosis was consid-
ered to include hypervascularity, noninvasive bone irrita-
tion, hormone-mediated osteoblast stimulation, tumor-
induced bone formation, and direct tumor invasion.1
Herein, we report a case of an advanced ENB with hy-
perostosis of the anterior skull base, in which the hyper-
ostotic bone was maximally resected. In addition, we
review relevant literature.
2. Case Report
A 44-year-old man having a 3-year history of nasal
obstruction and anosmia experienced worsened vision in his
right eye and right side facial numbness 1 year ago. The
patient had no history of alcohol, tobacco, or drug use. A
neurological examination revealed total anosmia,
decreased right visual acuity (VA; right eye, light sense
only; left eye, 1.0), impaired visual field (VF; generalized
defect, right), proptosis of the right eye with moderately
limited eyeball movement in all directions, and mild
hypoesthesia in the right malar area. Cervical lymph nodes
were not palpable, and blood tests revealed no abnormal-
ities. Nasal endoscopy disclosed a large reddish tumor in
the right middle meatus. Brain computed tomography (CT)
and magnetic resonance imaging (MRI) revealed an exten-
sively enhanced soft tissue tumor involving bilateral nasal
and orbital cavities, ethmoid sinuses, the floor of the
anterior cranial fossa, and intradural invasion. Beneath the
intracranial skull base tumor growth, prominent hyperos-
tosis was observed on both sides of the orbital roofs,
particularly on the right side (Figure 1). The soft tissue
tumor was removed from the nasal cavity by using an
endonasal approach, and pathological reports confirmed
ONB. A systemic survey revealed no distant metastasis, and
bifrontobasal craniotomy was performed for radically
removing the soft tissue mass, including intradural exten-
sion. Furthermore, the dural opening was repaired using a
temporalis muscle fascia graft. The bilateral hyperostosis
of the orbital roofs was drilled off to decompress the nar-
rowed orbital cavities, and the frontal skull base was
reconstructed using a pericranial flap. Pathological reports
confirmed ENB (Figure 2). The postoperative course was
uneventful, and the vision improved (VA, right: counting
finger, 20 cm; left: 1.0; VF: partial central defect, right).
After the operation, radiotherapy at a dose of 65 Gy and
adjuvant cisplatin-based chemotherapy were administered
according to the treatment guidelines. No tumor recur-
rence was observed after 1 year (Figure 3).
3. Discussion
ENB arises in the sinonasal tract and accounts for only
w3e6% of all intranasal tumors.2 ENB particularly arises in
the specialized olfactory epithelium lining the superiorportion of the upper nasal cavity. Because of its origin, this
locally expansive malignant tumor typically invades the
superomedial orbit, through the cribriform plate, and the
anterior cranial fossa.
Bone invasion occurs because of osteolysis and is
observed as a lytic image on CT.3 In extremely rare cases,
ENB can cause osteoblastic modification at bone destruc-
tion sites and result in exuberant bone formation. Only four
cases of hyperostotic ENB have been reported,1,4 with the
first being the case by Regenboger et al.4
According to the Kadish staging system, tumors are
divided into three groups: Group A lesions are confined to
the nasal cavity, Group B lesions involve the nasal cavity
and paranasal sinuses, and Group C lesions extend beyond
the paranasal sinuses to the orbital and cranial cavities.3
The present case was classified as Kadish Stage C, which
typically causes osteolysis of the anterior skull base and
bone remodeling to some extent. Hyperostosis is a rare
condition, and the abnormal bone was a noninvasive irri-
tation of the bone as well as a true bony invasion by the
Figure 2 (A) Hematoxylin and eosin staining of a tumor
section revealing benign respiratory epithelium-lined tissue
with submucosal nests of olfactory neuroblastoma composed of
nests of uniformly sized round blue cells and (B) immunohis-
tochemical staining for neuron-specific enolase (NSE) revealing
that the tumor is strongly diffuse positive for NSE.
Figure 3 Postoperative coronal images of contrast-enhanced
T1 weighted magnetic resonance imaging reveals the maximal
possible resection of the abnormal bones (arrows) and the
near-total excision of the extensively enhanced soft tissue
tumor.
Hyperostotic esthesioneuroblastoma 183tumor. The pathogenesis is similar to that of hyperostosis
associated with skull base meningiomas.1,5 These cases are
rare; therefore, the overall prognosis of the hyperostotic
variant of ENB remains undetermined. However, consid-
ering the extensive surrounding bony changes, Ramanathan
and Germanwala6 hypothesized that these tumors are
extremely aggressive. Accordingly, in this case, we admin-
istered chemotherapy in addition to radiotherapy.
A complete excision followed by radiotherapy at a dose
of 55e65 Gy is generally the standard treatment guideline.
For advanced ENBs, cisplatin-based chemotherapy is rec-
ommended as the concomitant treatment, either before or
during radiotherapy. The recommended chemotherapy
regimen includes the following drugs: cisplatin (60 mg/m2,
Day 4), 5-fluorouracil (5-FU; 600 mg/m2, given over 24 hours
for 5 days, Days 1e5), methotrexate (30 mg/m2, Day 1),
and leucovorin (20 mg/m2, Days 1e5). Both local recur-
rence and distant metastasis remain the major complica-
tions in the treatment of ONB because they may occur
several years after surgery alone. Therefore, the primary
treatment is extremely critical. For advanced ENBs, amultimodal strategy of treatment involving surgery with
postoperative radiotherapy and chemotherapy is recom-
mended.3 This approach is often successful for recurrent
disease and results in prolonged survival. Therefore, a
prolonged follow up is suitable for an appropriate identifi-
cation and treatment. No standardized protocol currently
exists because various follow-up regimens have been
advocated. Rimmer et al3 recommended a lifelong follow
up with both clinical examination and MRI scanning every 4
months for the first 2 years, every 6 months for the next 3
years, and then every 9 months thereafter.
In summary, we report an extensive ENB involving
bilateral nasal and orbital cavities, ethmoid sinuses, the
floor of the anterior cranial fossa, and intradural invasion.
Hyperostosis was observed on both sides of the orbital
roofs. Because of the actual structural constrictions and
potential tumor infiltration of the hyperostosis, we
recommend the maximal possible resection of the abnormal
bone while avoiding a neurovascular surgical insult.
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